Grant: CIHR Fellowship
McMaster University
$135,000.00
Determining how microbes lower blood glucose and insulin after bariatric surgery.
FY 2017-18
Summary
Half of the Canadian population is obese or overweight, which predisposes to serious health problems, such as high blood glucose and insulin, elevated blood lipids/cholesterol and hypertension. Obesity leads to type 2 diabetes (T2D), stroke and other chronic diseases that have high costs to public health care. However, we still do not understand why some obese people have high blood glucose and others do not and what actually causes the progression of prediabetes. The bacteria inhabiting our gut (i.e. gut microbiota) is now recognized as an important player controlling host metabolism. Bariatric surgery, the most efficacious intervention to cause remission of T2D, is associated with changes in the type of gut bacteria. Bariatric surgery also lowers blood glucose and insulin BEFORE weight loss. Nobody has fully tested HOW gut bacteria within a bariatric surgery patient change glucose and insulin control. We will use new ways to grow and identify bacteria from the same patient before and after 3 different types of bariatric surgery. We will also transplant the bacteria to germ free mice and determine how these microbes can lower blood glucose without the need for weight loss. We will look for novel species and bacterial molecules that can be used in the treatment and diagnosis of T2D.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
376485
Name
Forato Anhê Fernando
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Determining how microbes lower blood glucose and insulin after bariatric surgery.
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bariatric Surgery; Euglycemic-Hyperinsulinemic Clamps; Fecal Transplantation; Gnotobiotic Mice; Gut Microbiota; Immunometabolism; Metagenomics; Obesity; Type 2 Diabetes
Abstract
Half of the Canadian population is obese or overweight, which predisposes to serious health problems, such as high blood glucose and insulin, elevated blood lipids/cholesterol and hypertension. Obesity leads to type 2 diabetes (T2D), stroke and other chronic diseases that have high costs to public health care. However, we still do not understand why some obese people have high blood glucose and others do not and what actually causes the progression of prediabetes. The bacteria inhabiting our gut (i.e. gut microbiota) is now recognized as an important player controlling host metabolism. Bariatric surgery, the most efficacious intervention to cause remission of T2D, is associated with changes in the type of gut bacteria. Bariatric surgery also lowers blood glucose and insulin BEFORE weight loss. Nobody has fully tested HOW gut bacteria within a bariatric surgery patient change glucose and insulin control. We will use new ways to grow and identify bacteria from the same patient before and after 3 different types of bariatric surgery. We will also transplant the bacteria to germ free mice and determine how these microbes can lower blood glucose without the need for weight loss. We will look for novel species and bacterial molecules that can be used in the treatment and diagnosis of T2D.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Forato Anhê, Fernando
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~